The IRS Comes for UnitedHealth’s Foreign Profits in a High-Stakes Transfer Pricing Battle

By: Christian Pierce

(SeaPRwire) –   UnitedHealth Group is currently locked in a fierce dispute with the Internal Revenue Service over how it priced transactions with a foreign subsidiary between the 2017 and 2020 tax years. The IRS is pushing to significantly increase the healthcare giant’s taxable income for each of those years, leaving billions in potential adjustments hanging in the balance. Instead of folding, UnitedHealth disclosed in its August filing that it plans to vigorously contest these proposed adjustments.

This clash highlights a long-standing initiative by federal tax authorities to scrutinize multinational corporations that allocate profits across international borders. Tax experts note that transfer pricing examinations of this scale have become routine since the Obama administration ramped up enforcement against profit-shifting. Similar disputes have targeted corporate heavyweights like Coca-Cola, Meta, and Medtronic, often dragging on for decades and involving sums that run well into the billions.

Despite the gravity of the situation, public disclosures remain frustratingly sparse. UnitedHealth’s quarterly filings in May and August offer no details on where the subsidiary is based, what transactions triggered the audit, or what exact dollar amount the IRS is chasing. While the company reported that its gross unrecognized tax benefits rose to $5.6 billion at the end of 2025, management insists this total reflects reserves across all uncertain tax positions and has cautioned against tying that figure directly to this ongoing NOPA.

Author bio: Christian Pierce, a chief financial columnist and markets commentator specializing in corporate tax disputes, regulatory enforcement, and macroeconomic fiscal policy trends.